Clinical trials recruiting for Non-small Cell Carcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Anti-PD-(L)1 based immunotherapy | 1 |
| DO-2 | 1 |
| Docetaxel monotherapy | 1 |
| L-SABR | 1 |
| PF-08046054 | 1 |
| Platinum based chemotherapy | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 2 |
| New Jersey | 2 |
| New York | 2 |
| Pennsylvania | 2 |
| Alabama | 1 |
| Alaska | 1 |
| Arkansas | 1 |
| California | 1 |
| Colorado | 1 |
| Delaware | 1 |
| Georgia | 1 |
| Illinois | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
- A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
- Physical Activity Coaching After Surgery for Patients With Resectable Non-small Cell Lung Cancer
- Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
Related conditions
Trials recruiting for Non-small Cell Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Non-small Cell Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.